F Mainard

701 total citations
21 papers, 561 citations indexed

About

F Mainard is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, F Mainard has authored 21 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in F Mainard's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cancer, Lipids, and Metabolism (5 papers). F Mainard is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Lipoproteins and Cardiovascular Health (9 papers) and Cancer, Lipids, and Metabolism (5 papers). F Mainard collaborates with scholars based in France and Canada. F Mainard's co-authors include Claire Bonithon‐Kopp, Claudine Berr, Pierre‐Jean Touboul, Dominique Courbon, Pierre Ducimetière, Charles Coudray, Jean-Louis Auget, Alain Favier, A M Roussel and Josiane Arnaud and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Clinical Chemistry and Heart.

In The Last Decade

F Mainard

20 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Mainard France 8 253 192 172 122 97 21 561
Paolo Pauciullo Italy 14 281 1.1× 212 1.1× 302 1.8× 81 0.7× 23 0.2× 34 624
Caroline Marcoux Canada 9 144 0.6× 245 1.3× 204 1.2× 32 0.3× 45 0.5× 9 513
Elisa Campos United States 10 232 0.9× 482 2.5× 401 2.3× 31 0.3× 78 0.8× 16 778
Josephine Fong United States 7 101 0.4× 360 1.9× 123 0.7× 61 0.5× 131 1.4× 9 697
Tatsuji Kanoh Japan 10 192 0.8× 36 0.2× 231 1.3× 90 0.7× 29 0.3× 24 423
Giovanni Cerasola Italy 15 370 1.5× 191 1.0× 77 0.4× 67 0.5× 64 0.7× 32 739
Matti Nikkilä Finland 14 153 0.6× 263 1.4× 251 1.5× 70 0.6× 43 0.4× 22 712
Fumihiko Kamezaki Japan 11 122 0.5× 54 0.3× 110 0.6× 131 1.1× 31 0.3× 27 445
Jaana M. Leppälä Finland 6 129 0.5× 51 0.3× 95 0.6× 85 0.7× 103 1.1× 6 608
Cathy Williamson United Kingdom 6 106 0.4× 150 0.8× 83 0.5× 17 0.1× 91 0.9× 7 434

Countries citing papers authored by F Mainard

Since Specialization
Citations

This map shows the geographic impact of F Mainard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Mainard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Mainard more than expected).

Fields of papers citing papers by F Mainard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Mainard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Mainard. The network helps show where F Mainard may publish in the future.

Co-authorship network of co-authors of F Mainard

This figure shows the co-authorship network connecting the top 25 collaborators of F Mainard. A scholar is included among the top collaborators of F Mainard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Mainard. F Mainard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berr, Claudine, Charles Coudray, Claire Bonithon‐Kopp, et al.. (1998). Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study.. PubMed. 68(1). 26–35. 33 indexed citations
2.
Bigot, Edith, et al.. (1997). Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration. Clinica Chimica Acta. 265(1). 99–111. 4 indexed citations
3.
Coudray, Charles, A M Roussel, F Mainard, Josiane Arnaud, & Alain Favier. (1997). Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France).. PubMed. 16(6). 584–91. 80 indexed citations
4.
Bigot‐Corbel, Edith, et al.. (1996). [HDL-cholesterol or apolipoprotein AI: which parameter to choose?].. PubMed. 54(10-11). 349–52. 1 indexed citations
5.
Bonithon‐Kopp, Claire, Pierre‐Jean Touboul, Claudine Berr, et al.. (1996). Relation of Intima-Media Thickness to Atherosclerotic Plaques in Carotid Arteries. Arteriosclerosis Thrombosis and Vascular Biology. 16(2). 310–316. 233 indexed citations
6.
Mainard, F, et al.. (1994). Effect of storage of sera and apolipoprotein(a) phenotypes on detection of lipoprotein(a) by a new agarose gel. Clinica Chimica Acta. 225(2). 195–201. 3 indexed citations
7.
Duflos, Muriel, et al.. (1994). Synthesis and hypolipidemic activity of N-pyridinyl borodipeptidylamides. European Journal of Medicinal Chemistry. 29(11). 883–888. 1 indexed citations
8.
Mainard, F, et al.. (1994). Comparative study of risk factors in patients undergoing coronary or femoropopliteal artery bypass grafting.. Heart. 72(6). 542–547. 2 indexed citations
9.
Mainard, F, et al.. (1992). [Serum myoglobin: evaluation of two immunolatex methods. Comparison with a radioimmunoassay method].. PubMed. 50(3). 143–7. 1 indexed citations
10.
Masson, David, et al.. (1992). Effect of precipitation and centrifugation conditions on high-density lipoprotein cholesterol measured with phosphotungstate-magnesium reagent.. PubMed. 38(1). 148–148. 1 indexed citations
11.
Massoubre, Catherine, et al.. (1991). Immunonephelometric assay of myoglobin. Clinica Chimica Acta. 201(3). 223–229. 5 indexed citations
13.
Mainard, F, et al.. (1990). Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery. Clinical Chemistry. 36(11). 1889–1891. 47 indexed citations
14.
Mainard, F, et al.. (1988). Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction. Atherosclerosis. 69(2-3). 225–231. 12 indexed citations
15.
Mainard, F, et al.. (1988). Variations in the composition of low- and high-density lipoproteins during the acute phase of myocardial infarction.. PubMed. 34(1). 139–40. 6 indexed citations
16.
Mainard, F, et al.. (1988). [Lipid evaluation in cerebral infarction in its early phase and in the 4th month. Practical consequences].. PubMed. 17(23). 1204–5. 4 indexed citations
17.
Mainard, F, et al.. (1987). Are ‘precipitated LDL’ really low density lipoproteins?. Clinica Chimica Acta. 162(2). 141–146. 4 indexed citations
18.
Mainard, F, et al.. (1986). [Cholesterol, phospholipid and apoB composition of LDL: comparison of precipitation and ultracentrifugation methods].. PubMed. 44(6). 618–23. 4 indexed citations
19.
Mainard, F, et al.. (1985). Study of a myoglobin test in patients hospitalized for suspected myocardial infarction. Clinica Chimica Acta. 153(1). 1–8. 11 indexed citations
20.
Mainard, F, et al.. (1984). Hyperviscosité sanguine et plasmatique au cours des hyperlipidémies primitives. La Revue de Médecine Interne. 5(1). 29–33. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026